Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06686901 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06686901: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06686901 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06686901, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims to evaluate the acceptability, safety, and efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.
Interventions
- BEHAVIORAL Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S)
- BEHAVIORAL Smartphone-delivered inactive Therapeutic Evaluative Conditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2027-04-01 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06686901
The ClinicalTrials.gov registry entry for NCT06686901 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S) is the first listed.
NCT06686901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06686901 about?
NCT06686901 is a clinical study titled "A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior". This study aims to evaluate the acceptability, safety, and efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.
What is the current status of trial NCT06686901?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2027-04-01. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT06686901?
The interventions under investigation include: Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S) (BEHAVIORAL), Smartphone-delivered inactive Therapeutic Evaluative Conditioning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06686901?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.